“Classified research constitutes a much smaller portion of the U.S. biodefense program than many might suspect,” according to Gerald L. Epstein, a specialist at the Center for Strategic and International Studies.
“Nevertheless, classified DHS biodefense research will constitute one of the most controversial parts of the U.S. biodefense program,” he observed in Congressional testimony (pdf) earlier this month.
“Even more so than in other areas of science, the biological sciences have enjoyed a tradition of openness and international collaboration–and this heavy presumption of openness should continue. Since disease continues to kill millions of people around the world each year, any restrictions on relevant scientific knowledge could have serious consequences,” he told a House Science Subcommittee.
“Yet the existence of hostile, witting adversaries that are determined to wreak devastation and that are known to be interested in biological weapons mandates that this openness not be absolute.”
In March 8 testimony (at pp. 6-8), Dr. Epstein presented his views on how to reconcile these conflicting imperatives.
At a time when universities are already facing intense pressure to re-envision their role in the S&T ecosystem, we encourage NSF to ensure that the ambitious research acceleration remains compatible with their expertise.
FAS CEO Daniel Correa recently spoke with Adam Marblestone and Sam Rodriques, former FAS fellows who developed the idea for FROs and advocated for their use in a 2020 policy memo.
In a year when management issues like human capital, IT modernization, and improper payments have received greater attention from the public, examining this PMA tells us a lot about where the Administration’s policy is going to be focused through its last three years.
Congress must enact a Digital Public Infrastructure Act, a recognition that the government’s most fundamental responsibility in the digital era is to provide a solid, trustworthy foundation upon which people, businesses, and communities can build.